FALANGA, ANNA
FALANGA, ANNA
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
Tromboxane synthetase inhibition results in increased platelet sensivity to prostacyclin. Thrombosis and Haemostasis
1982 Bertelé, V; Falanga, A; Roncaglioni, M; Cerletti, C; De Gaetano, G
Unbalanced plasma control of TxA2 and PGI2 synthesis in Vitamin E deficient rats
1983 Falanga, A; Doni, M; Delaini, F; de Bellis Vitti, G; Imberti, L; Donati, M; Gaetano, G
The effect of Vitamin E or selenium on the oxidant-antioxidant balance in rats
1984 Doni, M; Falanga, A; Delaini, F; Vicenzi, E; Tomasiak, M; Donati, M
Pharmacological inhibition of thromboxane-synthetase and platelet aggregation: Modulatory role of cyclooxygenase products.
1984 Bertelé, V; Falanga, A; Tomasiak, M; Chiabrando, C; Cerletti, C; De Gaetano, G
Vitamin K-Dependent Procoagulant in Cancer Cells: A Potential Target for the Antimetastatic Effect of Warfarin?
1986 Donati, M; Roncaglioni, M; Falanga, A; Casali, B; Semeraro, N
Several murine metastatizing tumors possess a cysteine proteinase with cancer procoagulant characteristics
1987 Falanga, A; Bolognese D’Alessandro, A; Casali, B; Roncaglioni, M; Donati, M
Procoagulant activity of mouse transformed cells: Different expression in freshly isolated or cultured cells
1988 Curatolo, L; Alessio, M; Casali, B; Falanga, A; Donati, M; Semeraro, N
Visual associative agnosia and optic aphasia. A single case study and a review of the syndromes
1992 Iorio, L; Falanga, A; Fragassi, N; Grossi, D
INEFFICACY OF INTRAVENOUS IMMUNOGLOBULIN IN PATIENTS WITH LOW-RISK THROMBOTIC THROMBOCYTOPENIC PURPURA/HEMOLYTIC-UREMIC SYNDROME
1992 Finazzi, G; Bellavita, P; Falanga, A; Viero, P; Barbui, T
Supranormal antithrombin III levels induced by concentrate administration are ineffective in quenching thrombin generation in acute promyelocytic leukemia
1993 Rodeghiero, F; Castaman, G; Gugliotta, L; Mattioli Belmonte, M; Falanga, A; Bottasso, B; Barbui, T; Mannucci, P
Preliminary study to identify cancer patients at high risk of venous thrombosis following major surgery
1993 Falanga, A; Ofosu, F; Cortelazzo, S; Delaini, F; Consonni, R; Caccia, R; Longatti, S; Maran, D; Rodeghiero, F; Pogliani, E; Marassi, A; D’Angelo, A; Barbui, T
THE HYPERCOAGULABLE STATE IN CANCER-PATIENTS - EVIDENCE FOR IMPAIRED THROMBIN INHIBITIONS
1994 Falanga, A; Ofusu, F; Delaini, F; Oldani, E; Dewar, L; Lui, L; Barbui, T
RECOMBINANT VERSUS HIGH-SENSITIVITY CONVENTIONAL THROMBOPLASTIN - A RANDOMIZED CLINICAL-STUDY IN PATIENTS ON ORAL ANTICOAGULATION
1994 Finazzi, G; Falanga, A; Galli, M; Cortelazzo, S; Remuzzi, A; Barbui, T
Loss of blast cell procoagulant activity and improvement of hemostatic variables in patients with acute promyelocytic leukemia administered all-trans-retinoic acid
1995 Falanga, A; Iacoviello, I; Evangelista, V; Belotti, D; Consonni, R; D'Orazio, A; Robba, L; Donati, M; Barbui, T
The impact of all-trans-retinoic acid on the coagulopathy of acute promyelocytic leukemia
1998 Barbui, T; Finazzi, G; Falanga, A
The effect of very-low-dose warfarin on markers of hypercoagulation in metastatic breast cancer: Results from a randomized trial
1998 Falanga, A; Levine, M; Consonni, R; Gritti, G; Delaini, F; Oldani, E; Julian, J; Barbui, T
Polymorphonuclear leukocyte activation and hemostasis in patients with essential thrombocythemia and polycythemia vera
2000 Falanga, A; Marchetti, M; Evangelista, V; Vignoli, A; Licini, M; Balicco, M; Manarini, S; Finazzi, G; Cerietti, C; Barbui, T
Tumor cell prothrombotic properties
2001 Falanga, A
Molecular basis for the relationship between thrombosis and cancer
2001 Rickles, F; Falanga, A
Proceedings of the Second “International Conference on Thrombosis and Hemostasis Issues in Cancer”. September 19-21, 2003. Bergamo, Italy
2003 Falanga, A; Brenner, B; Rickles, F